159 related articles for article (PubMed ID: 6683634)
1. The influence of age on the DNA ploidy levels of breast tumours.
Taylor IW; Musgrove EA; Friedlander ML; Foo MS; Hedley DW
Eur J Cancer Clin Oncol; 1983 May; 19(5):623-8. PubMed ID: 6683634
[TBL] [Abstract][Full Text] [Related]
2. Tumour DNA ploidy as an independent prognostic factor in breast cancer.
Kallioniemi OP; Blanco G; Alavaikko M; Hietanen T; Mattila J; Lauslahti K; Koivula T
Br J Cancer; 1987 Nov; 56(5):637-42. PubMed ID: 3426929
[TBL] [Abstract][Full Text] [Related]
3. Effect of tamoxifen upon cell DNA analysis by flow cytometry in primary carcinoma of the breast.
Baildam AD; Zaloudik J; Howell A; Barnes DM; Moore M; Sellwood RA
Br J Cancer; 1987 May; 55(5):561-6. PubMed ID: 3606948
[TBL] [Abstract][Full Text] [Related]
4. [Flow cytophotometry parameters, hormone receptors and axillary lymph node status as prognostic factors in primary breast cancer].
Kaufmann M; Feichter GE; Nhila A; Klinga K; Abel U
Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):705-9. PubMed ID: 3234702
[TBL] [Abstract][Full Text] [Related]
5. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens.
Dressler LG; Seamer LC; Owens MA; Clark GM; McGuire WL
Cancer; 1988 Feb; 61(3):420-7. PubMed ID: 3338012
[TBL] [Abstract][Full Text] [Related]
6. [Epithelial growth factor receptors (EGF-R) and DNA flow cytometry in addition to lymph node and hormone receptor status as prognostic factors in primary breast cancer].
Costa SD; Kaufmann M; Fabbro D; Tokus M; Feichter G; Klinga K; Bastert G
Geburtshilfe Frauenheilkd; 1989 Apr; 49(4):375-8. PubMed ID: 2544476
[TBL] [Abstract][Full Text] [Related]
7. Correlation of DNA flow cytometry and hormone receptors with axillary lymph node status in patients with carcinoma of the breast.
Friedman NS; Freedman MD
Md Med J; 1994 Nov; 43(11):963-5. PubMed ID: 7808198
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome.
Fernö M; Baldetorp B; Borg A; Olsson H; Sigurdsson H; Killander D
Acta Oncol; 1992; 31(2):157-65. PubMed ID: 1622630
[TBL] [Abstract][Full Text] [Related]
9. [Flow cytometry detected S-phase fraction and ploidy as prognostic parameters in primary, node-negative breast cancer].
Winter K; Eidtmann H; Jonat W
Geburtshilfe Frauenheilkd; 1994 May; 54(5):291-4. PubMed ID: 8050690
[TBL] [Abstract][Full Text] [Related]
10. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
Pinto AE; André S; Soares J
J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
[TBL] [Abstract][Full Text] [Related]
11. Relationship between DNA ploidy and survival in patients with primary breast cancer.
Eskelinen MJ; Pajarinen P; Collan Y; Pesonen E; Alhava E; Kettunen K; Nordling S
Br J Surg; 1989 Aug; 76(8):830-4. PubMed ID: 2765840
[TBL] [Abstract][Full Text] [Related]
12. DNA ploidy and S-phase fraction in primary breast carcinomas in relation to prognostic factors and survival for premenopausal patients at high risk for recurrent disease.
Lykkesfeldt AE; Balslev I; Christensen IJ; Larsen JK; Mølgaard H; Rasmussen BB; Thorpe S; Rose C
Acta Oncol; 1988; 27(6A):749-56. PubMed ID: 3219225
[TBL] [Abstract][Full Text] [Related]
13. Correlation of DNA flow cytometric results and other prognostic factors in primary breast cancer.
Feichter GE; Mueller A; Kaufmann M; Haag D; Born IA; Abel U; Klinga K; Kubli F; Goerttler K
Int J Cancer; 1988 Jun; 41(6):823-8. PubMed ID: 3372059
[TBL] [Abstract][Full Text] [Related]
14. Node negative breast cancer: the prognostic value of DNA ploidy for long-term survival.
Yuan J; Hennessy C; Corbett IP; Dykin R; Givan AL; Shenton BK; Henry JA; Wright C; Lennard TW
Br J Surg; 1991 Jul; 78(7):844-8. PubMed ID: 1678669
[TBL] [Abstract][Full Text] [Related]
15. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
[TBL] [Abstract][Full Text] [Related]
16. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma.
Bosari S; Lee AK; Tahan SR; Figoni MA; Wiley BD; Heatley GJ; Silverman ML
Cancer; 1992 Oct; 70(7):1943-50. PubMed ID: 1525770
[TBL] [Abstract][Full Text] [Related]
17. The flow-cytometric analysis of DNA content and S-phase fraction (SPF) of human breast cancer.
Eskelinen M; Nordling S; Puittinen J; Pesonen E; Collan Y
Pathol Res Pract; 1989 Nov; 185(5):694-7. PubMed ID: 2626377
[TBL] [Abstract][Full Text] [Related]
18. Relationship of DNA ploidy to hormone receptor status and proliferation in invasive breast carcinoma.
Spiethoff A; Schenck A; Bohrer M
J Cancer Res Clin Oncol; 2000 Dec; 126(12):707-10. PubMed ID: 11153143
[TBL] [Abstract][Full Text] [Related]
19. Ploidy level of human breast carcinoma. Relation to histopathologic features and hormone receptor content.
Jakobsen A; Poulsen HS; Madsen EL; Petersen SE; Hansen HS
Acta Radiol Oncol; 1984; 23(2-3):103-7. PubMed ID: 6331077
[TBL] [Abstract][Full Text] [Related]
20. DNA ploidy and survival in breast cancer patients.
Cornelisse CJ; van de Velde CJ; Caspers RJ; Moolenaar AJ; Hermans J
Cytometry; 1987 Mar; 8(2):225-34. PubMed ID: 3582068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
